Sterling Capital Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$92.6K Buy
1,647
+1,472
+841% +$66.4K ﹤0.01% 1468
2026
Q2
$4.9K Sell
175
-139
-44% -$3.91K ﹤0.01% 2627
2026
Q1
$8.96K Sell
314
-2
-0.6% -$68 ﹤0.01% 2432
2025
Q4
$12.5K Buy
316
+199
+170% +$7.3K ﹤0.01% 2495
2025
Q3
$4.12K Hold
117
– – ﹤0.01% 2816
2025
Q2
$3.83K Sell
117
-199
-63% -$6.47K ﹤0.01% 2654
2025
Q1
$10.2K Sell
316
-245
-44% -$9.1K ﹤0.01% 1852
2024
Q4
$17.1K Buy
561
+469
+510% +$15.1K ﹤0.01% 1922
2024
Q3
$2.58K Hold
92
– – ﹤0.01% 2067

Other funds holding ATRC

Sterling Capital Management's ATRC Position: Q3 2026 in Review

Sterling Capital Management increased its AtriCure (ATRC) stake by 841% in Q3 2026, buying an estimated $66.4K and bringing the position to 1,647 shares worth $92.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1468.

Sterling Capital Management first reported a position in ATRC in Q3 2024 and has held it in 9 quarters since. 286 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Sterling Capital Management held 1,647 shares of AtriCure worth $92.6K as of Q3 2026.
  • Sterling Capital Management bought 1,472 AtriCure shares in Q3 2026, an estimated $66.4K.
  • AtriCure made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1468 holding.
  • Sterling Capital Management first reported a position in AtriCure in Q3 2024 and has held it in 9 quarters since.
  • 286 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.